References
- Ohlow M.J., Moosmann B. Phenothiazine: the seven lives of pharmacology’s first lead structure. Drug Discovery Today. 2011;16(3):119–131. doi: 10.1016/j.drudis.2011.01.001
- Seghatchian J., Struff W.G., Reichenberg S. Main properties of the THERAFLEX MB-plasma system for pathogen reduction. Transfusion Medicine and Hemotherapy. 2011;38(1):55–64. doi: 10.1159/000323786
- Gendrot M., Jardot P., Delandre O., Boxberger M., Andreani J., Duflot I., Le Bideau M., Mosnier J., Fonta I., Hutter S., La Scola B., Pradines B. In vitro evaluation of the antiviral activity of methylene blue alone or in combination against SARS-CoV-2. Journal of Clinical Medicine. 2021;10(14):3007. doi: 10.3390/jcm10143007
- Zhukhovitsky V., Shevlyagina N., Zubasheva M., Russu L., Gushchin V., Meerovich G., Strakhovskaya M. Infectivity and Morphology of Bovine Coronavirus Inactivated In Vitro by Cationic Photosensitizers. Viruses. 2022;14(5):1053. doi: 10.3390/v14051053
- Bojadzic D., Alcazar O., Buchwald P. Methylene blue inhibits the SARS-CoV-2 spike–ACE2 protein-protein interaction – a mechanism that can contribute to its antiviral activity against COVID-19. Frontiers in Pharmacology. 2021;11:600372. doi: 10.3389/fphar.2020.600372
- Fedorov V., Kholina E., Khruschev S., Kovalenko I., Rubin A., Strakhovskaya M. What Binds Cationic Photosensitizers Better: Brownian Dynamics Reveals Key Interaction Sites on Spike Proteins of SARS-CoV, MERS-CoV, and SARS-CoV-2. Viruses. 2021;13(8):1615. doi: 10.3390/v13081615
- Kovalenko I., Kholina E., Fedorov V., Khruschev S., Vasyuchenko E., Meerovich G., Strakhovskaya M. Interaction of Methylene Blue with Severe Acute Respiratory Syndrome Coronavirus 2 Envelope Revealed by Molecular Modeling. International Journal of Molecular Sciences. 2023;24(21):15909. doi: 10.3390/ijms242115909
- Vasyuchenko E.P., Kholina E.G., Fedorov V.A., Strakhovskaya M.G., Kovalenko I.B., Rubin A.B. Molecular modeling of the methylene blue interaction with the SARS-CoV-2 coronavirus viroporin. Vestnik Moskovskogo universiteta. Seriya 16. Biologiya. 2025;80(2):96–104. doi: 10.55959/MSU0137-0952-16-80-2-4
- Li Z., Lang Y., Sakamuru S., Samrat S., Trudeau N., Kuo L., Rugenstein N., Tharappel A., D'Brant L., Koetzner C.A., Hu S., Zhang J., Huang R., Kramer L.D., Butler D., Xia M., Li H. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus in vitro and in vivo. Emerging Microbes & Infections. 2020;9(1):2404–2416. doi: 10.1080/22221751.2020.1838954
- Kaufmann B., Rossmann M.G. Molecular mechanisms involved in the early steps of flavivirus cell entry. Microbes and Infection. 2011;13(1):1–9. doi: 10.1016/j.micinf.2010.09.005
- Carbaugh D.L., Lazear H.M. Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection and Pathogenesis. Journal of Virology. 2020;94(11). Article No. 10.1128/jvi.00104-20. doi: 10.1128/JVI.00104-20
- Fibriansah G., Tan J.L., Smith S.A., De Alwis R., Ng T.S., Kostyuchenko V.A., Jadi R.S., Kukkaro P., de Silva A.M., Crowe J.E., Lok S.-M. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nature Communications. 2015;6(1):6341. doi: 10.1038/ncomms7341
- Sirohi D., Chen Z., Sun L., Klose T., Pierson T.C., Rossmann M.G., Kuhn R.J. The 3.8 Å resolution cryo-EM structure of Zika virus. Science. 2016;352(6284):467–470. doi: 10.1126/science.aaf5316
- PDBFixer. https://github.com/openmm/pdbfixer (accessed 25 September 2025).
- Hornak V., Abel R., Okur A., Strockbine B., Roitberg A., Simmerling C. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins: Structure, Function, and Bioinformatics. 2006;65(3):712–725. doi: 10.1002/prot.21123
- Luger P., Dittrich B., Benecke L., Sterzel H. Charge density studies on methylene blue – a potential anti-Alzheimer agent. Zeitschrift für Naturforschung B. 2018;73(2):99–108. doi: 10.1515/znb-2017-0165
- Khruschev S.S., Abaturova A.M., Diakonova A.N., Ustinin D.M., Zlenko D.V., Fedorov V.A., Kovalenko I.B., Riznichenko G.Yu., Rubin A.B. Multi-particle Brownian Dynamics software ProKSim for protein-protein interactions modeling. Computer Research and Modeling. 2013;5(1):47–64. doi: 10.20537/2076-7633-2013-5-1-47-64
- Kim S.Y., Zhao J., Liu X., Fraser K., Lin L., Zhang X., Zhang F., Dordick J.S., Linhardt R.J. Interaction of Zika Virus Envelope Protein with Glycosaminoglycans. Biochemistry. 2017;56(8):1151–1162. doi: 10.1021/acs.biochem.6b01056
- Cheng M.L., Yang Y.X., Liu Z.Y., Wen D., Yang P., Huang X.Y., Dong H.L., Xu Y.P., Li X.F., Deng Y.Q. et al. Pathogenicity and structural basis of Zika variants with glycan loop deletions in the envelope protein. Journal of Virology. 2022;96(23). Article No. e00879-22. doi: 10.1128/jvi.00879-22
- Goo L., DeMaso C.R., Pelc R.S., Ledgerwood J.E., Graham B.S., Kuhn R.J., Pierson T.C. The Zika virus envelope protein glycan loop regulates virion antigenicity. Virology. 2018;515:191–202. doi: 10.1016/j.virol.2017.12.032
- Jolly C.L., Sattentau Q.J. Attachment Factors. In: Viral Entry into Host Cells. Eds. Pöhlmann S., Simmons G. New York: Springer, 2006. P. 1–23. doi: 10.1007/978-1-4614-7651-1_1
|
|
|